EndGenitor Technologies
Indianapolis
About EndGenitor Technologies
Founded in 2005, EGT combined the pioneering science of Dr. Merv Yoder and Dr. David Ingram with the extensive corporate and drug development experience of pharma/biotechnology veterans Mr. Ron Henriksen and Dr. Carlos Lopez.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $2.5M
- Last round: Series Unknown (Jul 2009)
- Website: endgenitor.com
- Phone: 13172753469
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/endgenitor-technologies-3260301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.